Aster Capital Management’s Latigo Biotherapeutics LTGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$145K Buy
+8,709
New +$184K 0.05% 392

Other funds holding LTGO

Aster Capital Management's LTGO Position: Q3 2026 in Review

Aster Capital Management opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 8,709 shares worth $145K. The stake represents 0.05% of the portfolio and ranks #392 among its holdings.

58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.

  • Aster Capital Management held 8,709 shares of Latigo Biotherapeutics worth $145K as of Q3 2026.
  • Latigo Biotherapeutics was a new Aster Capital Management position in Q3 2026.
  • Latigo Biotherapeutics made up 0.05% of Aster Capital Management's portfolio in Q3 2026, its #392 holding.
  • 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.